The roles of ribosomal protein S19 C-terminus in a shortened neutrophil lifespan through delta lactoferrin

Immunobiology

Volumn 220, Issue 9, 2015, Pages 1085-1092

  Nishiura, Hiroshi ^a   Yamanegi, Koji ^a   Kawabe, Mutsuki ^a   Kato Kogoe, Nahoko ^a   Yamada, Naoko ^a   Nakasho, Keiji ^a  

^a HYOGO COLLEGE OF MEDICINE   (Japan)

Author keywords

C5a receptor; Delta lactoferrin; Neutrophils; Regulator of G protein signaling 3; Ribosomal protein S19

Indexed keywords

COMPLEMENT COMPONENT C5A; COMPLEMENT COMPONENT C5A RECEPTOR; DELTA LACTOFERRIN; DIMETHYL SULFOXIDE; G PROTEIN COUPLED RECEPTOR; GUANINE NUCLEOTIDE BINDING PROTEIN ALPHA SUBUNIT; LACTOFERRIN; MANGANESE CHLORIDE; MITOGEN ACTIVATED PROTEIN KINASE P38; PHORBOL 13 ACETATE 12 MYRISTATE; RGS PROTEIN; RGS3 PROTEIN; RIBOSOME PROTEIN; RIBOSOME PROTEIN S19; UNCLASSIFIED DRUG; CALCIUM; GPRC5A PROTEIN, HUMAN; RGS3 PROTEIN, HUMAN; RIBOSOMAL PROTEIN S19;

APOPTOSIS; ARTICLE; CALCIUM TRANSPORT; CARBOXY TERMINAL SEQUENCE; CELL DIFFERENTIATION; CELL NUCLEUS; CELL SURVIVAL; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOPLASM; HL 60 CELL LINE; HUMAN; HUMAN CELL; MACROPHAGE; NEUTROPHIL; NEUTROPHIL CHEMOTAXIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; BIOSYNTHESIS; CELL MEMBRANE; CHEMOTAXIS; GENETICS; IMMUNOLOGY; ION TRANSPORT; LONGEVITY; METABOLISM; PHOSPHORYLATION; TUMOR CELL LINE;

APOPTOSIS; CALCIUM; CELL LINE, TUMOR; CELL MEMBRANE; CHEMOTAXIS; HL-60 CELLS; HUMANS; ION TRANSPORT; LACTOFERRIN; LONGEVITY; MACROPHAGES; NEUTROPHILS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; RECEPTORS, G-PROTEIN-COUPLED; RGS PROTEINS; RIBOSOMAL PROTEINS;

EID: 84983130704     PISSN: 01712985     EISSN: 18783279     Source Type: Journal    
DOI: 10.1016/j.imbio.2015.05.006     Document Type: Article

References (45)

1. Bansal G., Druey K.M., Xie Z. R4 RGS proteins: regulation of G-protein signaling and beyond. Pharmacol. Ther. 2007, 116:473.
2. Benaissa M., Peyrat J.P., Hornez L., Mariller C., Mazurier J., Pierce A. Expression and prognostic value of lactoferrin mRNA isoforms in human breast cancer. Int. J. Cancer 2005, 114:299.
3. Brazil T.J., Dixon P.M., Haslett C., Murray J., McGorum B.C. Constitutive apoptosis in equine peripheral blood neutrophils in vitro. Vet. J. 2014, 202:536.
4. Breton M., Mariller C., Benaissa M., Caillaux K., Browaeys E., Masson M., Vilain J.P., Mazurier J., Pierce A. Expression of delta-lactoferrin induces cell cycle arrest. Biometals 2004, 17:325.
5. Dalli J., Consalvo A.P., Ray V., Di Filippo C., D'Amico M., Mehta N., Perretti M. Proresolving and tissue-protective actions of annexin A1-based cleavage-resistant peptides are mediated by formyl peptide receptor 2/lipoxin A4 receptor. J. Immunol. 2013, 190:6478.
6. Dragovich T., Rudin C.M., Thompson C.B. Signal transduction pathways that regulate cell survival and cell death. Oncogene 1998, 17:3207.
7. El Kebir D., Gjorstrup P., Filep J.G. Resolvin E1 promotes phagocytosis-induced neutrophil apoptosis and accelerates resolution of pulmonary inflammation. Proc. Natl. Acad. Sci. U. S. A. 2012, 109:14983.
8. Falk W., Goodwin R.H., Leonard E.J. A 48-well micro chemotaxis assembly for rapid and accurate measurement of leukocyte migration. J. Immunol. Methods 1980, 33:239.
9. Findlay V.J., LaRue A.C., Turner D.P., Watson P.M., Watson D.K. Understanding the role of ETS-mediated gene regulation in complex biological processes. Adv. Cancer Res. 2013, 119:1.
10. Fukushima Y., Asano T., Saitoh T., Anai M., Funaki M., Ogihara T., Katagiri H., Matsuhashi N., Yazaki Y., Sugano K. Oligomer formation of histamine H2 receptors expressed in Sf9 and COS7 cells. FEBS Lett. 1997, 409:283.
11. Hoedt E., Chaoui K., Huvent I., Mariller C., Monsarrat B., Burlet-Schiltz O., Pierce A. SILAC-based proteomic profiling of the human MDA-MB-231 metastatic breast cancer cell line in response to the two antitumoral lactoferrin isoforms: the secreted lactoferrin and the intracellular delta-lactoferrin. PLOS ONE 2014, 9:e104563.
12. Hopken U.E., Lu B., Gerard N.P., Gerard C. The C5a chemoattractant receptor mediates mucosal defence to infection. Nature 1996, 383:86.
13. Hopken U.E., Lu B., Gerard N.P., Gerard C. Impaired inflammatory responses in the reverse arthus reaction through genetic deletion of the C5a receptor. J. Exp. Med. 1997, 186:749.
14. Horino K., Nishiura H., Ohsako T., Shibuya Y., Hiraoka T., Kitamura N., Yamamoto T. A monocyte chemotactic factor, S19 ribosomal protein dimer, in phagocytic clearance of apoptotic cells. Lab. Invest. 1998, 78:603.
15. Hsu W.C., Yang F.C., Lin C.H., Hsieh S.L., Chen N.J. C5L2 is required for C5a-triggered receptor internalization and ERK signaling. Cell. Signal. 2014, 26:1409.
16. Ihara A., Wada K., Yoneda M., Fujisawa N., Takahashi H., Nakajima A. Blockade of leukotriene B4 signaling pathway induces apoptosis and suppresses cell proliferation in colon cancer. J. Pharmacol. Sci. 2007, 103:24.
17. Ishii M., Kurachi Y. Physiological actions of regulators of G-protein signaling (RGS) proteins. Life Sci. 2003, 74:163.
18. Kehrl J.H. G-protein-coupled receptor signaling, RGS proteins, and lymphocyte function. Crit. Rev. Immunol. 2004, 24:409.
19. Knepper-Nicolai B., Savill J., Brown S.B. Constitutive apoptosis in human neutrophils requires synergy between calpains and the proteasome downstream of caspases. J. Biol. Chem. 1998, 273:30530.
20. Koselj-Kajtna M., Koselj M., Rott T., Kandus A., Bren A. Infectious complications of immunosuppressive treatment for anti-neutrophil cytoplasm antibody-related vasculitis. Transplant. Proc. 2002, 34:3001.
21. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970, 227:680.
22. Liu K., Paterson A.J., Chin E., Kudlow J.E. Glucose stimulates protein modification by O-linked GlcNAc in pancreatic beta cells: linkage of O-linked GlcNAc to beta cell death. Proc. Natl. Acad. Sci. U. S. A. 2000, 97:2820.
23. Liu D., Wang X., Zhang Z., Teng C.T. An intronic alternative promoter of the human lactoferrin gene is activated by Ets. Biochem. Biophys. Res. Commun. 2003, 301:472.
24. Mariller C., Hardiville S., Hoedt E., Huvent I., Pina-Canseco S., Pierce A. Delta-lactoferrin, an intracellular lactoferrin isoform that acts as a transcription factor. Biochem. Cell Biol. 2012, 90:307.
25. Matsubara S., Yamamoto T., Tsuruta T., Takagi K., Kambara T. Complement C4-derived monocyte-directed chemotaxis-inhibitory factor. A molecular mechanism to cause polymorphonuclear leukocyte-predominant infiltration in rheumatoid arthritis synovial cavities. Am. J. Pathol. 1991, 138:1279.
26. Milligan G. Constitutive activity and inverse agonists of G protein-coupled receptors: a current perspective. Mol. Pharmacol. 2003, 64:1271.
27. Nishimura T., Horino K., Nishiura H., Shibuya Y., Hiraoka T., Tanase S., Yamamoto T. Apoptotic cells of an epithelial cell line, AsPC-1, release monocyte chemotactic S19 ribosomal protein dimer. J. Biochem. 2001, 129:445.
28. Nishiura H. The alternative C5a receptor function. Adv. Exp. Med. Biol. 2013, 735:111.
29. Nishiura H., Shibuya Y., Matsubara S., Tanase S., Kambara T., Yamamoto T. Monocyte chemotactic factor in rheumatoid arthritis synovial tissue. Probably a cross-linked derivative of S19 ribosomal protein. J. Biol. Chem. 1996, 271:878.
30. Nishiura H., Shibuya Y., Yamamoto T. S19 ribosomal protein cross-linked dimer causes monocyte-predominant infiltration by means of molecular mimicry to complement C5a. Lab. Invest. 1998, 78:1615.
31. Nishiura H., Nonaka H., Revollo I.S., Semba U., Li Y., Ota Y., Irie A., Harada K., Kehrl J.H., Yamamoto T. Pro- and anti-apoptotic dual functions of the C5a receptor: involvement of regulator of G protein signaling 3 and extracellular signal-regulated kinase. Lab. Invest. 2009, 89:676.
32. Nishiura H., Tokita K., Li Y., Harada K., Woodruff T.M., Taylor S.M., Nsiama T.K., Nishino N., Yamamoto T. The role of the ribosomal protein S19 C-terminus in Gi protein-dependent alternative activation of p38 MAP kinase via the C5a receptor in HMC-1 cells. Apoptosis 2010, 15:966.
33. Nishiura H., Chen J., Ota Y., Semba U., Higuchi H., Nakashima T., Yamamoto T. Base of molecular mimicry between human ribosomal protein S19 dimer and human C5a anaphylatoxin. Int. Immunopharmacol. 2010, 10:1541.
34. Nishiura H., Zhao R., Yamamoto T. The role of the ribosomal protein S19 C-terminus in altering the chemotaxis of leukocytes by causing functional differences in the C5a receptor response. J. Biochem. 2011, 150:271.
35. Nishiura H., Zhao R., Chen J., Taniguchi K., Yamamoto T. Involvement of regional neutrophil apoptosis promotion by ribosomal protein S19 oligomers in resolution of experimental acute inflammation. Pathol. Int. 2013, 63:581.
36. Oda Y., Tokita K., Ota Y., Li Y., Taniguchi K., Nishino N., Takagi K., Yamamoto T., Nishiura H. Agonistic and antagonistic effects of C5a-chimera bearing S19 ribosomal protein tail portion on the C5a receptor of monocytes and neutrophils, respectively. J. Biochem. 2008, 144:371.
37. Oubrahim H., Chock P.B., Stadtman E.R. Manganese(II) induces apoptotic cell death in NIH3T3 cells via a caspase-12-dependent pathway. J. Biol. Chem. 2002, 277:20135.
38. Parente L., Solito E. Annexin 1: more than an anti-phospholipase protein. Inflamm. Res. 2004, 53:125.
39. Perianayagam M.C., Balakrishnan V.S., Pereira B.J., Jaber B.L. C5a delays apoptosis of human neutrophils via an extracellular signal-regulated kinase and Bad-mediated signalling pathway. Eur. J. Clin. Invest. 2004, 34:50.
40. Revollo I., Nishiura H., Shibuya Y., Oda Y., Nishino N., Yamamoto T. Agonist and antagonist dual effect of the cross-linked S19 ribosomal protein dimer in the C5a receptor-mediated respiratory burst reaction of phagocytic leukocytes. Inflamm. Res. 2005, 54:82.
41. Sanghavi D.M., Thelen M., Thornberry N.A., Casciola-Rosen L., Rosen A. Caspase-mediated proteolysis during apoptosis: insights from apoptotic neutrophils. FEBS Lett. 1998, 422:179.
42. Shi L., Tsurusaki S., Futa N., Sakamoto T., Matsuda T., Nishino N., Kunitomo R., Kawasuji M., Tokita K., Yamamoto T. Monocyte chemotactic S19 ribosomal protein dimer in atherosclerotic vascular lesion. Virchows Arch. 2005, 447:747.
43. Siebert P.D., Huang B.C. Identification of an alternative form of human lactoferrin mRNA that is expressed differentially in normal tissues and tumor-derived cell lines. Proc. Natl. Acad. Sci. U. S. A. 1997, 94:2198.
44. Thomassen E.A., van Veen H.A., van Berkel P.H., Nuijens J.H., Abrahams J.P. The protein structure of recombinant human lactoferrin produced in the milk of transgenic cows closely matches the structure of human milk-derived lactoferrin. Transgenic Res. 2005, 14:397.
45. Zinzar S., Ohnuma T., Holland J.F. Effects of simultaneous and sequential exposure to granulocytic and monocytic inducers on the choice of differentiation pathway in HL-60 promyelocytic leukemia cells. Leuk. Res. 1989, 13:23.